Literature DB >> 29602888

Pseudotumor cerebri as the presentation of Lyme disease in a non-endemic area.

Marta Ezequiel1, Ana Teresa Teixeira1, Maria João Brito1, Catarina Luís1.   

Abstract

Intracranial hypertension is a rare entity in prepubertal children, and its differential diagnosis includes a number of systemic diseases, drugs, vitamin deficiencies and excesses, and hereditary conditions. Infectious aetiology is rare. The case of a 9-year-old boy with intracranial hypertension secondary to acute neuroborreliosis is described. He presented with daily pulsatile frontotemporal headache, pallor, photophobia and phonophobia. His neurological examination revealed papilledema with no nuchal rigidity. The lumbar puncture showed increased pressure (50 cm H2O) and lymphocytic pleocytosis. Serum and cerebrospinal fluid (CSF) Borrelia burgdorferi antibodies were positive. This kind of infection is rare in Portugal but a trip to an endemic area was identified. A careful history, considering the exposure to rural areas together with the intracranial hypertension and inflammatory CSF, are important clues to the diagnosis, allowing the institution to select appropriate treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  headache (including migraines); meningitis; neuro-ophthalmology; tropical medicine (infectious disease)

Mesh:

Substances:

Year:  2018        PMID: 29602888      PMCID: PMC5884269          DOI: 10.1136/bcr-2017-222976

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Lyme disease complicated with pseudotumor cerebri.

Authors:  Jill A Nord; Dennis Karter
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

Review 2.  Lyme neuroborreliosis: infection, immunity, and inflammation.

Authors:  Andrew R Pachner; Israel Steiner
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

3.  Pseudotumor cerebri: early manifestation of adult Lyme disease.

Authors:  John E Castaldo; Erin Griffith; Daniel H Monkowski
Journal:  Am J Med       Date:  2008-07       Impact factor: 4.965

4.  Bilateral facial palsy: a form of neuroborreliosis presentation in paediatric age.

Authors:  Telma Francisco; Marília Marques; José Pedro Vieira; Maria João Brito
Journal:  BMJ Case Rep       Date:  2013-02-08

5.  A Presentation of Lyme Disease: Pseudotumor Cerebri.

Authors:  Burcu Şahin; Faruk İncecik; Özlem M Hergüner; Derya Alabaz; Şeyda Beşen
Journal:  Turk J Pediatr       Date:  2015 Sep-Oct       Impact factor: 0.552

6.  Neurologic manifestations in children with North American Lyme disease.

Authors:  A L Belman; M Iyer; P K Coyle; R Dattwyler
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

7.  [Isolated intracranial hypertension due to Lyme's disease].

Authors:  I Abadie; E Marc; J Bursztyn; M Assous; D Gendrel
Journal:  Arch Pediatr       Date:  2003-09       Impact factor: 1.180

8.  Lyme disease-related intracranial hypertension in children: clinical and imaging findings.

Authors:  Sriram Ramgopal; Rawad Obeid; Giulio Zuccoli; Catalina Cleves-Bayon; Andrew Nowalk
Journal:  J Neurol       Date:  2016-01-06       Impact factor: 4.849

Review 9.  Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.

Authors:  Hans-Walter Pfister; Tobias A Rupprecht
Journal:  Int J Med Microbiol       Date:  2006-03-09       Impact factor: 3.473

10.  Uncommon manifestations of neuroborreliosis in children.

Authors:  Matthias Baumann; Robert Birnbacher; Johannes Koch; Robert Strobl; Kevin Rostásy
Journal:  Eur J Paediatr Neurol       Date:  2009-09-12       Impact factor: 3.140

View more
  1 in total

Review 1.  Should Lumbar Puncture Be Required to Diagnose Every Patient With Idiopathic Intracranial Hypertension?

Authors:  Heather E Moss; Edward A Margolin; Andrew G Lee; Gregory P Van Stavern
Journal:  J Neuroophthalmol       Date:  2021-09-01       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.